High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles

The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inver...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2010-08, Vol.395 (1), p.290-297
Hauptverfasser: Mulet, Xavier, Kennedy, Danielle F., Conn, Charlotte E., Hawley, Adrian, Drummond, Calum J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 297
container_issue 1
container_start_page 290
container_title International journal of pharmaceutics
container_volume 395
creator Mulet, Xavier
Kennedy, Danielle F.
Conn, Charlotte E.
Hawley, Adrian
Drummond, Calum J.
description The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inverse bicontinuous cubic and inverse hexagonal liquid crystalline nanoparticles loaded with 10 commonly used therapeutic agents at increasing concentration. The dispersions are prepared using automated apparatus to create different concentrations and phases using novel protocols. We are able to characterise each stabilised nanoparticle dispersion using a range of methodologies including small angle X-ray scattering, particle sizing and drug partitioning. With this information we are able to assess which drug delivery vehicle is preferred for each drug and at which concentration the drug should be loaded to ensure maximum payload and to retain particle integrity.
doi_str_mv 10.1016/j.ijpharm.2010.05.029
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754563221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S037851731000390X</els_id><sourcerecordid>754563221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-9fc42ba62205ccb800500f5f98937c4e740c7e7f9084bb652268fa4d1a2d07e83</originalsourceid><addsrcrecordid>eNqFkU1rHDEMhk1paDZpf0LLXEpPs5XtsT1zKiU0SSHQS3o2Ho9mx8t81R8L-ffxdjftMSAQEs8rCb2EfKSwpUDl1_3W7dfB-GnLIPdAbIE1b8iG1oqXvFLyLdkAV3UpqOKX5CqEPQBIRvk7cslA1KAauSHp3u2GIg5-SbthTbFYPa7Gm-iWuTBzV9i8w9iI3oVTc-kLM62DyzE6W8xmXkL0ycbksftbZn10No0mYtH5tCs6HN0B_VNxwMHZEcN7ctGbMeCHc74mv29_PN7clw-_7n7efH8obcVkLJs-59ZIlu-1tq0BBEAv-qZuuLIVqgqsQtU3UFdtKwVjsu5N1VHDOlBY82vy5TR39cufhCHqyQWL42hmXFLQSlRCcpaf8irJeVNT3hxJcSKtX0Lw2OvVu8n4J01BH63Re322Rh-t0SB0tibrPp03pHbC7p_qxYsMfD4DJlgz9t7M1oX_HAcq8sDMfTtxmD93cOh1sA5ni53zaKPuFvfKKc8ttbIP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733981391</pqid></control><display><type>article</type><title>High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mulet, Xavier ; Kennedy, Danielle F. ; Conn, Charlotte E. ; Hawley, Adrian ; Drummond, Calum J.</creator><creatorcontrib>Mulet, Xavier ; Kennedy, Danielle F. ; Conn, Charlotte E. ; Hawley, Adrian ; Drummond, Calum J.</creatorcontrib><description>The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inverse bicontinuous cubic and inverse hexagonal liquid crystalline nanoparticles loaded with 10 commonly used therapeutic agents at increasing concentration. The dispersions are prepared using automated apparatus to create different concentrations and phases using novel protocols. We are able to characterise each stabilised nanoparticle dispersion using a range of methodologies including small angle X-ray scattering, particle sizing and drug partitioning. With this information we are able to assess which drug delivery vehicle is preferred for each drug and at which concentration the drug should be loaded to ensure maximum payload and to retain particle integrity.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2010.05.029</identifier><identifier>PMID: 20580796</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Automation, Laboratory ; Biological and medical sciences ; Chemistry, Pharmaceutical ; Cubosome ; Drug Carriers ; Drug delivery ; Drug Stability ; Fatty Alcohols - chemistry ; General pharmacology ; Glycerides - chemistry ; Hexosome ; High-throughput ; High-Throughput Screening Assays ; Liquid Crystals - chemistry ; Lyotropic liquid crystal ; Medical sciences ; Nanoparticles ; Particle Size ; Pharmaceutical Preparations - chemistry ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Scattering, Small Angle ; Solubility ; Spectrophotometry ; Technology, Pharmaceutical - methods ; X-Ray Diffraction</subject><ispartof>International journal of pharmaceutics, 2010-08, Vol.395 (1), p.290-297</ispartof><rights>2010</rights><rights>2015 INIST-CNRS</rights><rights>Crown Copyright (c) 2010. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-9fc42ba62205ccb800500f5f98937c4e740c7e7f9084bb652268fa4d1a2d07e83</citedby><cites>FETCH-LOGICAL-c426t-9fc42ba62205ccb800500f5f98937c4e740c7e7f9084bb652268fa4d1a2d07e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2010.05.029$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23015201$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20580796$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulet, Xavier</creatorcontrib><creatorcontrib>Kennedy, Danielle F.</creatorcontrib><creatorcontrib>Conn, Charlotte E.</creatorcontrib><creatorcontrib>Hawley, Adrian</creatorcontrib><creatorcontrib>Drummond, Calum J.</creatorcontrib><title>High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inverse bicontinuous cubic and inverse hexagonal liquid crystalline nanoparticles loaded with 10 commonly used therapeutic agents at increasing concentration. The dispersions are prepared using automated apparatus to create different concentrations and phases using novel protocols. We are able to characterise each stabilised nanoparticle dispersion using a range of methodologies including small angle X-ray scattering, particle sizing and drug partitioning. With this information we are able to assess which drug delivery vehicle is preferred for each drug and at which concentration the drug should be loaded to ensure maximum payload and to retain particle integrity.</description><subject>Automation, Laboratory</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical</subject><subject>Cubosome</subject><subject>Drug Carriers</subject><subject>Drug delivery</subject><subject>Drug Stability</subject><subject>Fatty Alcohols - chemistry</subject><subject>General pharmacology</subject><subject>Glycerides - chemistry</subject><subject>Hexosome</subject><subject>High-throughput</subject><subject>High-Throughput Screening Assays</subject><subject>Liquid Crystals - chemistry</subject><subject>Lyotropic liquid crystal</subject><subject>Medical sciences</subject><subject>Nanoparticles</subject><subject>Particle Size</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Scattering, Small Angle</subject><subject>Solubility</subject><subject>Spectrophotometry</subject><subject>Technology, Pharmaceutical - methods</subject><subject>X-Ray Diffraction</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rHDEMhk1paDZpf0LLXEpPs5XtsT1zKiU0SSHQS3o2Ho9mx8t81R8L-ffxdjftMSAQEs8rCb2EfKSwpUDl1_3W7dfB-GnLIPdAbIE1b8iG1oqXvFLyLdkAV3UpqOKX5CqEPQBIRvk7cslA1KAauSHp3u2GIg5-SbthTbFYPa7Gm-iWuTBzV9i8w9iI3oVTc-kLM62DyzE6W8xmXkL0ycbksftbZn10No0mYtH5tCs6HN0B_VNxwMHZEcN7ctGbMeCHc74mv29_PN7clw-_7n7efH8obcVkLJs-59ZIlu-1tq0BBEAv-qZuuLIVqgqsQtU3UFdtKwVjsu5N1VHDOlBY82vy5TR39cufhCHqyQWL42hmXFLQSlRCcpaf8irJeVNT3hxJcSKtX0Lw2OvVu8n4J01BH63Re322Rh-t0SB0tibrPp03pHbC7p_qxYsMfD4DJlgz9t7M1oX_HAcq8sDMfTtxmD93cOh1sA5ni53zaKPuFvfKKc8ttbIP</recordid><startdate>20100816</startdate><enddate>20100816</enddate><creator>Mulet, Xavier</creator><creator>Kennedy, Danielle F.</creator><creator>Conn, Charlotte E.</creator><creator>Hawley, Adrian</creator><creator>Drummond, Calum J.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100816</creationdate><title>High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles</title><author>Mulet, Xavier ; Kennedy, Danielle F. ; Conn, Charlotte E. ; Hawley, Adrian ; Drummond, Calum J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-9fc42ba62205ccb800500f5f98937c4e740c7e7f9084bb652268fa4d1a2d07e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Automation, Laboratory</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical</topic><topic>Cubosome</topic><topic>Drug Carriers</topic><topic>Drug delivery</topic><topic>Drug Stability</topic><topic>Fatty Alcohols - chemistry</topic><topic>General pharmacology</topic><topic>Glycerides - chemistry</topic><topic>Hexosome</topic><topic>High-throughput</topic><topic>High-Throughput Screening Assays</topic><topic>Liquid Crystals - chemistry</topic><topic>Lyotropic liquid crystal</topic><topic>Medical sciences</topic><topic>Nanoparticles</topic><topic>Particle Size</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Scattering, Small Angle</topic><topic>Solubility</topic><topic>Spectrophotometry</topic><topic>Technology, Pharmaceutical - methods</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulet, Xavier</creatorcontrib><creatorcontrib>Kennedy, Danielle F.</creatorcontrib><creatorcontrib>Conn, Charlotte E.</creatorcontrib><creatorcontrib>Hawley, Adrian</creatorcontrib><creatorcontrib>Drummond, Calum J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulet, Xavier</au><au>Kennedy, Danielle F.</au><au>Conn, Charlotte E.</au><au>Hawley, Adrian</au><au>Drummond, Calum J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2010-08-16</date><risdate>2010</risdate><volume>395</volume><issue>1</issue><spage>290</spage><epage>297</epage><pages>290-297</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inverse bicontinuous cubic and inverse hexagonal liquid crystalline nanoparticles loaded with 10 commonly used therapeutic agents at increasing concentration. The dispersions are prepared using automated apparatus to create different concentrations and phases using novel protocols. We are able to characterise each stabilised nanoparticle dispersion using a range of methodologies including small angle X-ray scattering, particle sizing and drug partitioning. With this information we are able to assess which drug delivery vehicle is preferred for each drug and at which concentration the drug should be loaded to ensure maximum payload and to retain particle integrity.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>20580796</pmid><doi>10.1016/j.ijpharm.2010.05.029</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2010-08, Vol.395 (1), p.290-297
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_754563221
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Automation, Laboratory
Biological and medical sciences
Chemistry, Pharmaceutical
Cubosome
Drug Carriers
Drug delivery
Drug Stability
Fatty Alcohols - chemistry
General pharmacology
Glycerides - chemistry
Hexosome
High-throughput
High-Throughput Screening Assays
Liquid Crystals - chemistry
Lyotropic liquid crystal
Medical sciences
Nanoparticles
Particle Size
Pharmaceutical Preparations - chemistry
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Scattering, Small Angle
Solubility
Spectrophotometry
Technology, Pharmaceutical - methods
X-Ray Diffraction
title High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T08%3A54%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20throughput%20preparation%20and%20characterisation%20of%20amphiphilic%20nanostructured%20nanoparticulate%20drug%20delivery%20vehicles&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Mulet,%20Xavier&rft.date=2010-08-16&rft.volume=395&rft.issue=1&rft.spage=290&rft.epage=297&rft.pages=290-297&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2010.05.029&rft_dat=%3Cproquest_cross%3E754563221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733981391&rft_id=info:pmid/20580796&rft_els_id=S037851731000390X&rfr_iscdi=true